Literature DB >> 28163553

Pharmaceutical Approval Update.

Michele B Kaufman.   

Abstract

Prasterone (Intrarosa) for the treatment of dyspareunia due to menopause; crisaborole (Eucrisa) for the topical treatment of atopic dermatitis; and tenofovir alafenamide (Vemlidy) for once-daily treatment of chronic hepatitis B virus infection.

Entities:  

Year:  2017        PMID: 28163553      PMCID: PMC5265233     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  1 in total

Review 1.  A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada.

Authors:  Yonah Krakowsky; Ethan D Grober
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.